{"id":"https://openalex.org/W136336507","doi":"https://doi.org/10.1177/135965350501000509","title":"Efficacy and Safety of Once-Daily Combination Therapy with Didanosine, Lamivudine and Nevirapine in Antiretroviral-Naive HIV-Infected Patients","display_name":"Efficacy and Safety of Once-Daily Combination Therapy with Didanosine, Lamivudine and Nevirapine in Antiretroviral-Naive HIV-Infected Patients","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W136336507","doi":"https://doi.org/10.1177/135965350501000509","mag":"136336507","pmid":"https://pubmed.ncbi.nlm.nih.gov/16152754"},"language":"en","primary_location":{"id":"doi:10.1177/135965350501000509","doi":"https://doi.org/10.1177/135965350501000509","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000509","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000509","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000509","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001003748","display_name":"Esteban Ribera","orcid":"https://orcid.org/0000-0002-3752-8808","observed_orcids":["https://orcid.org/0000-0002-3752-8808"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Esteban Ribera","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025711711","display_name":"Dolors Rodr\u00edguez-Pardo","orcid":"https://orcid.org/0000-0001-6781-5405","observed_orcids":["https://orcid.org/0000-0001-6781-5405"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Dolors Rodr\u00edguez-Pardo","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104354892","display_name":"Manuel Rubio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050926","display_name":"Hospital Universitari Arnau de Vilanova","ror":"https://ror.org/01p3tpn79","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050926","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Rubio","raw_affiliation_strings":["Internal Medicine Service, Hospital Arnau de Vilanova, Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine Service, Hospital Arnau de Vilanova, Lleida, Spain","institution_ids":["https://openalex.org/I2802050926"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Soler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Soler","raw_affiliation_strings":["HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023915997","display_name":"Enric Pedrol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enric Pedrol","raw_affiliation_strings":["HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100772675","display_name":"Jos\u00e9 Lu\u00eds Blanco","orcid":"https://orcid.org/0000-0003-2010-2744","observed_orcids":["https://orcid.org/0000-0003-2010-2744"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 L Blanco","raw_affiliation_strings":["Infectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101753470","display_name":"Alicia Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-2265-8976","observed_orcids":["https://orcid.org/0000-0002-2265-8976"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alicia Gonz\u00e1lez","raw_affiliation_strings":["Department of Internal Medicine \u2013 Infectious Diseases, Hospital del Mar, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine \u2013 Infectious Diseases, Hospital del Mar, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111848971","display_name":"M. Crespo Casal","orcid":"https://orcid.org/0000-0001-9016-0515","observed_orcids":["https://orcid.org/0000-0001-9016-0515"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manel Crespo","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062643699","display_name":"Vicen\u00e7 Falc\u00f3","orcid":"https://orcid.org/0000-0001-9626-0023","observed_orcids":["https://orcid.org/0000-0001-9626-0023"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vicen\u00e7 Falc\u00f3","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087175375","display_name":"Imma Ocan\u0303a","orcid":"https://orcid.org/0000-0003-3699-0790","observed_orcids":["https://orcid.org/0000-0003-3699-0790"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Imma Oca\u00f1a","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074510707","display_name":"Elisabeth Deig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabeth Deig","raw_affiliation_strings":["HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Unit, Department of Internal Medicine, Fundaci\u00f3 Hospital de Granollers, Granollers, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113685861","display_name":"Jos\u00e9 M. Mir\u00f3","orcid":"https://orcid.org/0000-0001-8057-7755","observed_orcids":["https://orcid.org/0000-0001-8057-7755"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose M Mir\u00f3","raw_affiliation_strings":["Infectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108083876","display_name":"Albert Pahissa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050926","display_name":"Hospital Universitari Arnau de Vilanova","ror":"https://ror.org/01p3tpn79","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050926","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert Pahissa","raw_affiliation_strings":["Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","Internal Medicine Service, Hospital Arnau de Vilanova, Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Internal Medicine Service, Hospital Arnau de Vilanova, Lleida, Spain","institution_ids":["https://openalex.org/I2802050926"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":2.3462,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.86829685,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"5","first_page":"605","last_page":"614"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9800000190734863},{"id":"https://openalex.org/keywords/didanosine","display_name":"didanosine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":1.0},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.9599999785423279},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.890999972820282},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.800000011920929},{"id":"https://openalex.org/keywords/drug-resistance-mutations","display_name":"drug resistance mutations","score":0.8809999823570251},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7749999761581421},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5}],"concepts":[{"id":"https://openalex.org/C2777447569","wikidata":"https://www.wikidata.org/wiki/Q422606","display_name":"Didanosine","level":5,"score":0.917648434638977},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.9061749577522278},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.8133700489997864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6708043813705444},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5829673409461975},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.47085040807724},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.46299228072166443},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4343443810939789},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.42179322242736816},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.3933987021446228},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3750452995300293},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32537609338760376},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.15182924270629883},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.09414157271385193}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016049","descriptor_name":"Didanosine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016049","descriptor_name":"Didanosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016049","descriptor_name":"Didanosine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/135965350501000509","doi":"https://doi.org/10.1177/135965350501000509","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000509","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000509","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:16152754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16152754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1177/135965350501000509","doi":"https://doi.org/10.1177/135965350501000509","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350501000509","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350501000509","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W136336507.pdf","grobid_xml":"https://content.openalex.org/works/W136336507.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W4992121","https://openalex.org/W1978283204","https://openalex.org/W1987983524","https://openalex.org/W1988633607","https://openalex.org/W1991979996","https://openalex.org/W2004293828","https://openalex.org/W2018158288","https://openalex.org/W2019029192","https://openalex.org/W2022188917","https://openalex.org/W2024438075","https://openalex.org/W2028598015","https://openalex.org/W2044880884","https://openalex.org/W2048864317","https://openalex.org/W2052332986","https://openalex.org/W2054105441","https://openalex.org/W2056779298","https://openalex.org/W2059164477","https://openalex.org/W2061682103","https://openalex.org/W2065188893","https://openalex.org/W2070972927","https://openalex.org/W2071686284","https://openalex.org/W2083477796","https://openalex.org/W2107227728","https://openalex.org/W2118047663","https://openalex.org/W2136097824","https://openalex.org/W2137523454","https://openalex.org/W2141776019","https://openalex.org/W2144890980","https://openalex.org/W2151288869","https://openalex.org/W2152293167","https://openalex.org/W2159019521","https://openalex.org/W2159797384","https://openalex.org/W2161076042","https://openalex.org/W2162776180","https://openalex.org/W2315299016","https://openalex.org/W2317283086","https://openalex.org/W2407521229","https://openalex.org/W2410311867","https://openalex.org/W3028262166"],"related_works":["https://openalex.org/W2410311867","https://openalex.org/W1992249780","https://openalex.org/W2411093836","https://openalex.org/W1978283204","https://openalex.org/W2053053844","https://openalex.org/W2061682103","https://openalex.org/W1989983978","https://openalex.org/W2131011957","https://openalex.org/W2406018938","https://openalex.org/W2405990315"],"abstract_inverted_index":{"BACKGROUND:":[0],"Simplified":[1],"antiretroviral":[2],"regimens":[3],"are":[4],"needed":[5],"to":[6,20,196,206,232,275],"improve":[7],"patient":[8],"adherence":[9],"and":[10,24,36,66,111,139,214,235,237,240,272,280],"quality":[11],"of":[12,16,26,31,77,126,132,145,174,210,220,242,260,269],"life.":[13],"The":[14,70,148,249],"purpose":[15],"this":[17],"study":[18,187],"was":[19,48,58,74,108,116,150,180,190,252],"evaluate":[21],"the":[22,75,100,136,172,186,258],"efficacy":[23],"safety":[25],"a":[27,49,80,129,143,165,255],"once-daily":[28,267],"regimen":[29,282],"consisting":[30],"didanosine":[32],"(ddI),":[33],"lamivudine":[34,65],"(3TC)":[35],"nevirapine":[37],"(NVP)":[38],"for":[39],"adult":[40],"antiretroviral-naive":[41,284],"patients":[42,78,96,127,154,175,183,194,222],"with":[43,79,155,164,176,223,254],"HIV-1":[44,106],"infection.":[45],"METHODS:":[46],"This":[47],"prospective,":[50],"one-arm,":[51],"multicentre":[52],"pilot":[53],"study.":[54,101],"Daily":[55],"drug":[56],"dosage":[57],"250":[59],"or":[60,208],"400":[61,67],"mg":[62,68],"didanosine,":[63],"300mg":[64],"nevirapine.":[69],"primary":[71],"outcome":[72],"measure":[73],"percentage":[76],"plasma":[81,105],"HIV-RNA":[82],"level":[83],"<50":[84,133],"copies/ml":[85,134],"at":[86,169,286,296],"12":[87],"months":[88],"on":[89],"an":[90,277],"intention-to-treat":[91],"(ITT)":[92],"basis.":[93],"RESULTS:":[94],"Seventy":[95],"were":[97],"enrolled":[98],"in":[99,135,153,162,192,199,203,212,216,257,283,288],"At":[102,119],"baseline,":[103,170],"mean":[104,112],"RNA":[107],"5.10log10":[109],"copies/ml,":[110],"CD4":[113,140,157,177],"cell":[114],"count":[115],"262":[117],"cells/microl.":[118,147],"month":[120],"12,":[121],"67%":[122],"(95%":[123],"CI:":[124],"56-78)":[125],"maintained":[128],"viral":[130],"load":[131],"ITT":[137],"analysis":[138],"counts":[141,158,178],"increased":[142],"median":[144],"201":[146],"treatment":[149],"more":[151],"effective":[152],"baseline":[156],">100":[159],"cells/microl":[160],"than":[161],"those":[163,289],"poorer":[166],"immunological":[167],"status":[168],"although":[171],"number":[173],"<100":[179],"low.":[181],"Four":[182],"died":[184],"during":[185],"period.":[188],"Therapy":[189],"discontinued":[191],"18":[193],"due":[195],"virological":[197,227],"failure":[198,228],"11,":[200],"adverse":[201],"events":[202],"seven,":[204],"loss":[205],"follow-up":[207],"withdrawal":[209],"consent":[211],"four":[213,241],"death":[215],"one.":[217],"Eight":[218],"out":[219],"nine":[221],"available":[224],"genotype":[225],"after":[226],"showed":[229],"resistance":[230,247],"mutations":[231],"NVP":[233,273],"(Y181C":[234],"others)":[236],"3TC":[238,271],"(M184V/I),":[239],"them":[243],"also":[244],"had":[245],"ddI":[246],"(L74V).":[248],"lipid":[250],"profile":[251],"favourable,":[253],"decrease":[256],"ratio":[259],"total-to-high":[261],"density":[262],"lipoprotein":[263],"cholesterol.":[264],"CONCLUSION:":[265],"A":[266],"combination":[268],"ddI,":[270],"seems":[274],"be":[276],"effective,":[278],"safe":[279],"easy-to-take":[281],"patients,":[285],"least":[287],"who":[290],"do":[291],"not":[292],"have":[293],"severe":[294],"immunodepression":[295],"baseline.":[297]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}